Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months. EB613 single ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

FDA committee recommends Amgen's denosumab, for the treatment, but not prevention, of bone loss, while Lilly decides not to submit arzoxifene for regulatory review after 5-year trial. Later this month ...

Microsoft found over 50 hidden prompts from 31 companies across 14 industries. The hidden prompts are designed to manipulate AI assistant memory through "Summarize with AI" buttons. The prompts use ...

Long-lasting treatment suppresses HIV in people with mental illness and other conditions that make it challenging to adhere to standard treatments.

Microsoft has implemented and continues to deploy mitigations against prompt injection attacks in Copilot, the company announced last week. Spammers were using the "Summarize with AI" type of buttons ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

Brad Zukeran ’24 is pursuing a major in environmental science and minors in political science and history at Santa Clara University. Zukeran was a 2022-23 environmental ethics fellow at the Markkula ...

Leqvio (inclisiran) may cause injection site reactions, including bruising, pain, discoloration, itchiness, and a burning or prickling sensation at the injection site. In addition to injection site ...

Mounjaro (tirzepatide) is a dual-acting medication that mimics GIP and GLP-1 hormones to reduce appetite and improve metabolic function. While this drug has been approved by the Food and Drug ...